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Summary
Inducible and reversible silencing of selected neurons
in vivo is critical tounderstanding the structure anddy-
namicsof brain circuits.WehavedevelopedMolecules
for Inactivation of Synaptic Transmission (MISTs) that
canbe genetically targeted to allow the reversible inac-
tivation of neurotransmitter release. MISTs consist
of modified presynaptic proteins that interfere with
the synaptic vesicle cycle when crosslinked by small
molecule ‘‘dimerizers.’’ MISTs based on the vesicle
proteinsVAMP2/SynaptobrevinandSynaptophysin in-
duced rapid (w10min) and reversible blockof synaptic
transmission in cultured neurons and brain slices. In
transgenic mice expressing MISTs selectively in Pur-
kinje neurons, administration of dimerizer reduced
learning and performance of the rotarod behavior.
MISTs allow for specific, inducible, and reversible le-
sions in neuronal circuits and may provide treatment
of disorders associated with neuronal hyperactivity.
Introduction
How does the activity in specific neuronal populations
contribute to physiological processes, behavioral re-
sponses, and disease states? Answering this question
will require tools that allow the modulation of specific
components of neural circuits in vitro and in vivo. Surgi-
cal lesion and pharmacological techniques have limited
specificity and other drawbacks. As a consequence,
there has been great interest in developing protein-
based approaches to inactivating neurons that could
be delivered using genetic techniques (Marek and Davis,
2003; Miesenbock, 2004).
Silencing by expression of K+ or Cl2 channels has
been useful in invertebrate and cultured neurons (Bur-
rone et al., 2002; Nitabach et al., 2002; Paradis et al.,
2001; White et al., 2001), but has yielded mixed results in
the mammalian brain in vivo (Nadeau et al., 2000; Suther-
land et al., 1999). To introduce temporal control, K+ or
Cl2 channels have been coupled to ligands without en-
dogenous receptors (Cully et al., 1994; Lechner et al.,
2002; Li et al., 2002; Scearce-Levie et al., 2001; Slimko
and Lester, 2003; Slimko et al., 2002), but these promis-
ing approaches have as yet only been demonstrated in
vitro. An elegant alternative involves blocking sodium
channels by expression of membrane-tethered toxins
*Correspondence: svoboda@cshl.edu(Ibanez-Tallon et al., 2004). Although this approach cir-
cumvents some of the problems associated with ex-
pression of exogenous channels, it does not allow rap-
idly inducible silencing.
Many presynaptic proteins are both essential and
specific for synaptic vesicle cycling, making them
good targets for the selective perturbation of neuro-
transmission (Fernandez-Chacon and Sudhof, 1999). In
Drosophila, expression of a temperature-sensitive mu-
tation of shibire (Dynamin) allows conditional inactiva-
tion of synaptic transmission (Dubnau et al., 2001;
Kawasaki et al., 2000; Kitamoto, 2001, 2002; McGuire
et al., 2001). In mammalian systems, specific inactiva-
tion of synaptic activity has been limited to transcrip-
tionally inducible expression of the tetanus toxin light
chain (TeTxLc) (Yamamoto et al., 2003; Yu et al., 2004).
However, the time course of both induction and reversal
is very slow, and leaky expression of the potent toxin is
problematic.
Here, we describe the development of Molecular sys-
tems for inducible and reversible Inactivation of Synap-
tic Transmission (MISTs). MISTs interfere with synaptic
transmission by chemical induction of dimerization
(CID) of modified synaptic proteins. CID is caused by
small molecules (dimerizers) with surfaces that can
bind simultaneously to two protein modules of either
the same (homodimerizers) or different type (heterodi-
merizers) (Crabtree and Schreiber, 1996; Rivera, 1998;
Spencer et al., 1993). CID can be used to regulate bio-
logical processes that depend on protein-protein inter-
actions (Clackson, 1997; Rivera, 1998). A particularly
successful approach relies on the reversible binding
of the FK506 binding protein (FKBP) and the FKBP-
rapamycin binding domain (FRB) that is induced by non-
toxic derivatives of rapamycin or FK506 (Crabtree and
Schreiber, 1996). Fusion of variants of FKBP and FRB
to proteins of interest allows inducible homodimerization
and heterodimerization under the control of small cell-
permeable molecules. This approach has been used to
control signal transduction in cells (Amara et al., 1997;
Belshaw et al., 1996; Moskowitz et al., 2003; Muthu-
swamy et al., 2001) and in intact animals (Jin et al., 2000;
Mallet et al., 2002). MISTs rely on CID of synaptic pro-
teins with themselves (homo-MIST) or with other modi-
fied synaptic proteins (hetero-MIST). We provide exam-
ples of both types of MISTs and focus in detail on
experiments using a MIST based on homo-oligomeriza-
tion of VAMP2/Synaptobrevin (VAMP/Syb MIST).
Results
Screen for Chemical Inactivation
of Synaptic Transmission
Given the complex spatiotemporal sequence of protein-
protein interactions leading to vesicle fusion, we rea-
soned that sequestration of an essential player by CID
might cause perturbation of synaptic transmission. Po-
tential MISTs fall into at least two classes: those that
rely on inducible crosslinking of synaptic vesicle (SV)
proteins and those that rely on sequestering SV proteins
Neuron
728Figure 1. FM Dye Screen for CID-Mediated Inactivation of Synaptic Transmission
(A) Schematics showing four candidate MISTs. VAMP/Syb MIST, homodimerization of VAMP2/Synaptobrevin; Sph-Sph MIST, homodimeriza-
tion of Synaptophysin; Sph-Bcl-2 MIST, crosslinking Synaptophysin to the mitochondrial membrane; Sph-StxTM MIST, crosslinking Synapto-
physin to the plasma membrane. Abbreviations: Sph, Synaptophysin; VAMP/Syb, VAMP2/Synaptobrevin; StxTM, transmembrane domain of
Syntaxin 1A; MITO, mitochondrion; FKBP, FK506 binding protein; FKBP*, FKBP with Phe36Val mutation; FRB, FKBP-rapamycin binding domain
of FRAP. (B) Schematic view of the three conditions compared in the screen: 100 mM Cd2+ (minimal loading), dimerizer, or vehicle (maximal load-
ing). Red dots represent presynaptic boutons stained with FM 4-64. Axons are untransfected (black) or transfected (green), and only transfected
axons were analyzed. (C) The time course of the protocol used to induce the inactivation of synaptic transmission and to stain boutons with FM 4-
64. (D) (Top) Image of a transfected axon expressing Synaptophysin-EGFP-FRB (green) stained with FM 4-64 (red) and CellTracker Blue (blue).
The axon backbone is indicated as a white line. (Bottom) Intensity along the axon backbone in the three fluorescence channels. (E) The Block
index for four potential MISTs and control (VenusYFP). Numbers above each bar represent the number of independent experiments, each con-
sisting of three to four coverslips in all conditions. *p < 0.001. (F) Reversal of CID-dependent inactivation of synaptic vesicle cycling after washout
of the dimerizer. *p < 0.01. Error bars represent 6SEM.away from their site of action. On the basis of genetic
and biochemical data alone, it is difficult to predict an ef-
fective strategy for silencing synaptic transmission by
CID. We therefore generated a panel of w20 candidate
MISTs consisting of fusions between SV proteins and
FKBP or FRB (a subset is illustrated in Figure 1A). These
include MISTs based on oligomerization of synaptic pro-
teins by intravesicular (VAMP/Syb MIST) or intervesicu-
lar (Synaptophysin(Sph)-Sph MIST) crosslinking and
MISTs based on inducible crosslinking of synaptic pro-
teins to mitochondria (Sph-Bcl-2 MIST) or the plasma
membrane (Sph-Syntaxin TransMembrane domain
[StxTM] MIST).
We screened for CID-mediated inactivation of synap-
tic transmission in dissociated cultured neurons. Cells
were transfected with candidate MISTs, and activity-dependent synaptic vesicle cycling was assayed by
imaging FM 4-64 fluorescence in synaptic terminals
(Figure 1). Within each experiment, we established the
dynamic range of the assay by measuring FM 4-64 load-
ing with intact vesicle cycling (vehicle; negative control)
and vesicle cycling abolished by blockade of voltage-
dependent Ca2+ channels (Cd2+; positive control). We
further measured FM 4-64 fluorescence in the presence
of the dimerizer. We calculated a ‘‘block index’’ (BI;
range 0–1) that measures how close the dimerizer condi-
tion was to the positive (BI = 1) and negative (BI = 0) con-
trols under our stimulus conditions. The screen revealed
two systems that significantly reduced synaptic vesicle
cycling in the presence of the corresponding dimerizer:
VAMP/Syb MIST (BI = 0.456 0.05; p < 0.001, Student’s t
test) and Sph-StxTM MIST (BI = 0.59 6 0.07; p < 0.001,
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729Student’s t test) (Figure 1E). For both systems, CID-
dependent inactivation of synaptic vesicle cycling was
reversed after the dimerizer was washed out (reversal:
VAMP/Syb MIST, 97.7%; Sph-StxTM MIST, 50.9%) (Fig-
ure 1F). Given the ease of transgene delivery and full re-
versibility of the one-component VAMP/Syb MIST, it was
chosen for detailed analysis.
We did not expect the expression of VAMP/Syb MIST
by itself to perturb presynaptic function as it is similar
to the well-characterized synaptopHluorin reporter
(Miesenbock et al., 1998; Sankaranarayanan and Ryan,
2000). We verified this further by measuring activity-
dependent vesicle cycling using FM 4-64 in dissociated
cultures transduced with lentiviral vectors expressing
VAMP/Syb MIST or EGFP. There were no significant dif-
ferences in the size of the total recycling pool (Ryan
et al., 1996b) or in the destaining kinetics (Ryan et al.,
1996a) in the two populations of synapses (Figure 2).
Inactivation of Excitatory and Inhibitory
Synaptic Transmission
CID-dependent inactivation of excitatory synaptic trans-
mission was further characterized using whole-cell mea-
surements of excitatory postsynaptic currents (EPSCs)
in acute brain slices. MISTs were introduced into layer
(L) 3 cells in vivo using in utero viral vector-mediated
gene delivery (VAMP/Syb MIST) or electroporation
(Sph-StxTM MIST) (Figure 3A). In the barrel cortex, L2
neurons receive ascending input from L3 neurons
Figure 2. Destaining Kinetics and the Size of the Releasable Pool
Are Not Significantly Different in EGFP-Expressing and VAMP/Syb
MIST-Expressing Neurons
(A) Experimental time course. (Top) Schematic of a synaptic terminal
with labeled membranes in pink. Neurons were stained by inducing
action potentials with field stimulation at 30 Hz in the presence of 10
mM FM 4-64. After ten baseline images were acquired, 30 Hz stimu-
lation resumed to induce destaining. (B) Destaining kinetics of FM 4-
64-stained synaptic terminals. Each point represents the normalized
intensity of ROIs averaged across coverslips. (C) Cumulative fre-
quency distributions of the fluorescence change (difference be-
tween ‘‘3’’ and ‘‘5’’ in [A]; this is a standard measure of the total re-
leasable pool of synaptic vesicles) for boutons of EGFP- (n = 5
coverslips; 1533 boutons) and VAMP/Syb-MIST- (n = 5 coverslips;
1095 boutons) expressing neurons. (D) Fluorescence change of
EGFP- and VAMP/Syb MIST-expressing neurons across coverslips.
Error bars represent 6SEM.(Bureau et al., 2004). We thus recorded synaptic cur-
rents in L2 neurons and evoked synaptic transmission
with an extracellular stimulation electrode placed in
a band of transfected/infected neurons in L3. Bath appli-
cation of either heterodimerizer, for the Sph-StxTM
MIST (AP21967, 500 nM; Figure 3B), or homodimerizer,
for the VAMP/Syb MIST (AP20187, 100 nM; Figures 3C
and 3D), reliably caused a rapid decrease in the ampli-
tude of monosynaptic EPSCs (Figure 3D; p < 0.0001,
Student’s t test). Inactivation was specific to treatment
with the chemical dimerizers, as addition of the vehicle
had no effect on synaptic transmission (Figure 3D). The
inactivation was also specific to neurons expressing
the MISTs, since even at much higher doses (1 mM) the
dimerizers had no effect on synaptic transmission in un-
infected slices.
Synaptobrevin/VAMP2 is known to be expressed in
GABAergic cells (Trimble et al., 1990), and cultured Syn-
aptobrevin/VAMP 2 knockout neurons exhibit a loss of
inhibitory synaptic transmission (Dr. T. Sudhof, personal
communication). Thus, we asked if VAMP/Syb MIST can
inducibly inactivate synaptic transmission at inhibitory
synapses. Inhibitory synaptic transmission was charac-
terized in dissociated cultured neurons. With excitatory
currents blocked (using the AMPA receptor blocker
NBQX [10 mM] and the NMDA receptor blocker (r)-CPP
[5 mM]), we evoked inhibitory postsynaptic currents
(IPSCs) by extracellular stimulation and measured IPSCs
with whole-cell recording techniques (Figure 3F). VAMP/
Syb MIST was introduced into neurons using viral
vector-mediated gene delivery. Infection efficiency
ranged 50%–75% (Figure 3E). Following bath applica-
tion of the dimerizer (100 nM AP20187) (Figures 3F and
3G), the amplitudes of IPSCs decreased (p < 0.01, Stu-
dent’s t test). Interestingly, CID-dependent inactivation
of IPSCs was more rapid than inactivationof EPSCs (com-
pare Figures 3C and 3F). Whereas 8.96 2.7 min were re-
quired for 50% inactivation of EPSCs (Figure 3D), only
2.2 6 0.1 min were required for inactivation of IPSCs
(Figure 3G). This is not likely due to a higher level of ex-
pression of VAMP/Syb MIST in interneurons in dissoci-
ated culture. In the in utero experiments, the construct
had been expressing in excitatory cells for 15–19 days
from the high-copy adenoviral vector. In contrast, in
dissociated culture experiments, the construct was
expressing in interneurons for 10–14 days from the
single-copy lentiviral vector. Thus, both the duration of
expression and the mode of delivery favored a higher
expression level in the excitatory cells.
We further tested the effects of VAMP/Syb MIST on
network activity in cultured neural networks. Robust net-
work activity was induced by blocking GABA-A recep-
tors with bicuculline (30 mM) (Figure 4A). Activity was
measured by current clamp in sister cultures treated
with either the dimerizer or the vehicle. Three to four
experiments with independent sets of sister coverslips
were performed. Within each experiment, we recorded
20–30 traces (5 s each) from five to seven pyramidal cells
per condition. As a simple measure of activity, we calcu-
lated the average standard deviation of the membrane
potential for each cell. The activity in each cell was then
normalized to the average activity in the vehicle con-
dition within the same experiment. The normalized activ-
ity for all cells within each condition was then pooled
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730Figure 3. CID-Mediated Inactivation of Excitatory and Inhibitory Synaptic Transmission
(A–D) VAMP/Syb and Sph-StxTM MIST-dependent block of excitatory synaptic transmission in brain slices (P9–P14). (A) Brain slice from a mouse
transduced in utero with adenoviral vectors for VAMP/Syb MIST and VenusYFP. (B and C) Examples of CID-mediated block of excitatory syn-
aptic transmission for Sph-StxTM MIST (B) and VAMP/Syb MIST (C). Insets show EPSCs during the baseline period (black) and after block (red).
(D) Average time course of VAMP/Syb MIST-dependent inactivation of excitatory synaptic transmission (black, transfected, with dimerizer,
n = 11; blue, transfected, with vehicle, n = 5; green, untransfected, with dimerizer, n = 3). Red bar indicates the time of dimerizer addition. Stimulus
rates were 0.1 Hz or 0.2 Hz. (E–G) VAMP/Syb-MIST-dependent block of inhibitory synaptic transmission in dissociated culture of hippocampal
neurons. (E) Dissociated neuronal culture transduced at plating with a bidirectional lentiviral vector expressing VAMP/Syb MIST and EGFP.
(F) Example of CID-mediated inactivation of monosynaptic inhibitory synaptic responses. Inset shows IPSCs during the baseline period (black)
and after block (red). (G) Average time course of VAMP/Syb MIST-dependent inactivation of inhibitory synaptic transmission (black, transfected,
with dimerizer, n = 3; blue, transfected, with vehicle, n = 3). Red bar indicates the time of dimerizer addition. Stimulus rate was 0.5 Hz.across experiments (Figures 4B and 4C). A robust block
of network activity (remaining activity, 0.31 6 0.036; p <
0.000001, Student’s t test) was observed following treat-
ment with the dimerizer. The fractional block was not
different after 1 hr or 3 hr of treatment with dimerizer
(Figure 4B; p > 0.3, Student’s t test).
We further characterized the time course of reversal of
the VAMP/Syb MIST-dependent block of network activ-
ity. In this series of experiments, we treated sister cul-
tures with: (1) vehicle for 3 hr (Figure 4C, Vehicle), (2)
dimerizer for 3 hr (Figure 4C, Dimerizer), (3) dimerizer
for 1 hr followed by medium for 1 hr (Figure 4C, Wash
1 hr), or (4) dimerizer for 1 hr followed by medium for
2 hr (Figure 4C, Wash 2 hr). Comparing activity under
these different conditions revealed that CID-mediated
inactivation of network activity in cultured neurons was
completely reversed following a 1 hr wash in medium
(Vehicle versus Wash 1 hr; p > 0.6, Student’s t test).
Inactivation of Cerebellar Purkinje Neurons In Vivo
VAMP/Syb MIST was further tested in the context of
cerebellum-dependent behavior. Purkinje cells provide
the output from the cerebellar cortex to the deep cere-
bellar nuclei, a projection that is believed to be involvedin motor learning and motor performance (Thach et al.,
1992). Previous studies have shown that absence of syn-
aptic transmission from granule to Purkinje cells leads to
specific deficits in motor learning and balance without
obvious ataxia (Hirai et al., 2003; Yamamoto et al.,
2003). In addition, mice with Purkinje cell degeneration
show reduced performance in a rotarod balance task
(Lalonde et al., 1996).
We expressed VAMP/Syb MIST under the control of
the L7 promoter in transgenic mice (Zhang et al.,
2001). The transgene was specifically expressed in
most cerebellar Purkinje cells (Figure 5A). Similar to find-
ings in previous studies (Hirai et al., 2003; Yamamoto
et al., 2003), our mice did not exhibit obvious ataxia fol-
lowing silencing by injection of the dimerizer. We asked
whether transient silencing of Purkinje neuron output
would interfere with the learning and performance of
the rotarod task. Mice were acquainted with the rotarod
task. Transgene expression by itself (i.e., in the absence
of dimerizer) had no effect on the average latency to fall
(Figure 5B). Dimerizer was injected into the lateral ven-
tricle either during or following the learning phase of
the task. CID caused a profound impairment of rotarod
performance during the learning phase of the task
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fected by genetic background (p < 0.00001) and drug
application (p < 0.0003) (two-way ANOVA). In addition,
there was a significant interaction between genetic
background and drug application (p < 0.0003), as is ex-
pected if drug application selectively perturbs motor co-
ordination in transgenic animals. The latency to fall of
transgenic animals (n = 9) was significantly different af-
ter the drug injection (Session 2) compared with the la-
tency to fall of wild-type animals (n = 8) in the same ses-
sion (p < 0.003; Student’s t test). One session (24 hr)
later, learning resumed at almost normal rates. Follow-
ing saturation of learning, CID caused a transient de-
crease in rotarod performance (Figure 5D), which was
reversed by 36 hr after injection. The latencies to fall
were significantly affected by genetic background (p <
0.0001) and drug application (p < 0.0002) (two-way AN-
OVA). The latency to fall of transgenic animals (n = 12)
was significantly different after the second drug injec-
tion (Session 3) than the latency to fall of wild-type ani-
Figure 4. VAMP/Syb MIST Reversibly Silences Network Activity
(A) Example of spontaneous activity over 5 s in dissociated cultures
(black, vehicle; red, dimerizer; green, reversal of the dimerizer treat-
ment). (B) Normalized spontaneous activity following 1 hr and 3 hr of
dimerizer treatment (n = 4 experiments). (C) Normalized spontane-
ous activity following dimerizer treatment (n = 6 experiments); fol-
lowing washout for 1 hr (n = 3 experiments); and following washout
for 2 hr (n = 4 experiments).mals (n=8) in the same session (p < 0.00001, Student’s
t test). In either type of experiment, wild-type littermates
were not affected by injection of the dimerizer (Figure 5D
and data not shown). Together, these results show that
motor learning and motor performance on the rotarod
task depend acutely on Purkinje cell output. These ex-
periments further demonstrate that VAMP/Syb MIST
can be used to specifically perturb the function of neural
circuits in vivo with temporal precision on the order of
a few hours.
Discussion
We have described a general approach for inducible in-
activation of synaptic transmission in genetically tar-
geted neuronal populations. Use of MISTs avoids prob-
lems that limit other strategies for silencing neurons.
Compared to methods employing membrane channels,
MISTs do not modify the neuron’s excitability. MISTs are
faster than methods that require transcriptional induc-
tion, such as production of tetanus toxin (Yamamoto
et al., 2003). Strong inactivation of excitatory and inhib-
itory synaptic transmission can be induced within 20 to
30 min of low-frequency stimulation. Reversal was dem-
onstrated over periods of 1 hr in vitro and 1 day in vivo
(Figures 4C and 5C). The time course of block and rever-
sal can likely be optimized by exploring the dose-
response curve and by using reversers (see Figure S1 in
the Supplemental Data available with this article online).
MISTs likely need to replace endogenous proteins to
act as inducible dominant-negatives. Protein expression
levels may therefore be an important determinant of
MIST efficacy. However, expression levels achievable
with infection using adenovirus (Figures 3A–3D) and len-
tivirus (Figures 3E–3G and 4), in utero transfection (Fig-
ure 3D), and transgenesis (Figure 5) all were sufficient
for potent CID-mediated inactivation. In our in vitro ex-
periments, inactivation of synaptic transmission was in
the range of 50% to 100%. In some experiments block
was almost complete (Figures 3B, 3C, and 3F). Given
that transfection and infection efficiencies were
<80% and that we could not exclude the possibility of
stimulation of untransfected axons of passage, the
observed block is remarkably high. Similarly, in ourFigure 5. Rotarod Behavior in Transgenic Mice Expressing VAMP/Syb MIST under the L7 Promoter in Purkinje Cells
(A) Coronal section of the cerebellum of an L7-VAMP/Syb MIST-IRES-EGFP transgenic mouse showing the expression of EGFP in Purkinje cells.
(B) Average latency to fall for transgenic and wild-type animals after saturation of learning. (C) Injection of dimerizer transiently abolished rotarod
learning in transgenic (blue line, nine animals), but not in wild-type (black line, eight animals) mice. *p < 0.003; **p < 0.05. (D) After learning sat-
urated, injection of dimerizer transiently reduced rotarod performance in transgenic (blue line, 12 animals), but not in wild-type (black line, nine
animals) mice. The vehicle controls were performed after a long recovery period. *p < 0.002; **p < 0.00001; ***p < 0.02. Data from experiments in
(C) and (D) are representative of two repeats with different sets of litters. Error bars represent 6SEM.
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genic mice, CID-dependent effects on rotarod learning
(Figure 5C) were as pronounced as those with expression
of tetanus toxin in granule cells (Yamamoto et al., 2003).
These experiments indicate that modest expression lev-
els of VAMP/Syb MIST in a variety of experimental situa-
tions suffice to allow a potent CID-mediated block.
Classic models of cerebellar learning implicate plas-
ticity at the parallel fiber synapse (Marr, 1969). The ability
of an acute perturbation of Purkinje cell output to inter-
fere with cerebellar learning contradicts the simplest
feed-forward version of this model. Our behavioral data
instead suggest that the intact cerebellum is required
for learning, or that other forms of plasticity, possibly
at the output of Purkinje cells (Aizenman et al., 1998),
contribute to cerebellar learning.
MISTs based on homodimerization and heterodimeri-
zation offer distinct advantages. For example, pro-
moters driving expression in specific cell types are
known only for a small number of neuronal subtypes
(Gong et al., 2003). Two-component systems could en-
able greater specificity since inactivation would occur
only in the intersection of the two expression patterns.
On the other hand, one-component systems allow easier
targeting in vivo. In combination with expression in de-
fined populations of neurons, MISTs offer the possibility
of genetic analysis of neural circuits.
In addition, MISTs could be used to selectively silence
specific projections. Many CNS neurons, such as neo-
cortical pyramidal neurons in L5, project to multiple
target areas, and it is critical to be able to separate the
contributions of the different projections. For example,
it has been difficult to assess the role of corticothalamic
feedback in cortical processing (Alitto and Usrey, 2003).
If a MIST could be expressed in L5 cortical pyramidal
neurons, localized injection of the dimerizers at the ter-
minals of a particular projection, in this case in the thal-
amus, would allow selective silencing of corticothalamic
feedback.
The applicability of MISTs to a particular experimental
situation will depend on the timescales involved. In re-
duced preparations, MISTs allow inactivation of synap-
tic transmission within tens of minutes. This time course
is sufficiently rapid for studies of network plasticity in vi-
tro (Burrone et al., 2002) (Pouille and Scanziani, 2004). In
vivo, the kinetics of drug delivery and clearance likely
determine CID-mediated inactivation. The half-life of
free dimerizer in the blood is about 5–6 hr, although
the half-life of the dimerizer bound to its target may be
longer (Dr. Victor Rivera, personal communication).
The half-life of dimerizer-induced inactivation of synap-
tic transmission will thus depend both on the half-life of
the dimerizer-target interaction and on the turnover rate
of the target. Long-term in vivo experiments likely would
require multiple rounds of dimerizer delivery (Jin et al.,
2000). In our behavioral experiments, CID-mediated ef-
fects were completely reversed after 48 hr (Figure 5).
However, the detailed kinetics of inactivation and rever-
sal will likely need to be determined on an individual
basis. For experiments requiring systemic delivery of
dimerizer, studies of blood-brain barrier penetration will
be required.
In cases in which MISTs are used for silencing of a brain
region, one potential pitfall might arise from an apparentlyfaster time course of inactivation of inhibitory synaptic
transmission as compared to that of excitatory synaptic
transmission (cf. Figures 3C and 3F). This difference in ki-
netics could lead to transient epileptic discharges in the
inactivated area. However, such discharges should be
quite transient, followed by inactivation of the entire re-
gion. Furthermore, this confound could be avoided with
the use of cell type-specific expression.
Although MISTs are based on synaptic proteins that
are believed to be largely specific to the process of neu-
rotransmitter release, we cannot fully exclude the possi-
bility that other cellular processes might depend on their
function. For example, recent reports have suggested
that VAMP2/Synaptobrevin might be important for traf-
ficking of GLUT4 (Martin et al., 1998) and TRPC3 (Singh
et al., 2004). Further investigation will be required to
evaluate whether CID-mediated perturbations of these
processes will occur and what the physiological conse-
quences of these perturbations might be.
Gene therapy based on MISTs may help to treat neuro-
logical disorders characterized by abnormally high neuro-
nal activity or excitotoxic damage, including epilepsy
(McNamara, 1999), Parkinson’s (Benabid, 2003) and Hun-
tington’s diseases (Hogarth, 2003), amyotrophic lateral
sclerosis (Bruijn,2002), dystonia (Hallett,2004), andstroke
(Abe and Zhang, 2003). In all of these disorders, drugs
that reduce synaptic activity, including benzodiazepines,
calcium channel blockers, and sodium channel blockers,
or drugs that reduce glutamate excitotoxicity have been
shown to significantly ameliorate symptoms and possibly
provide neuroprotection (Doble, 1999 and references
therein). Viral delivery of a genetically encoded silencing
system to affected parts of the nervous system may allow
more specific, tunable, and reversible treatment than do
currently available approaches.
Experimental Procedures
Constructs, Production of Viruses, and the Transgenic
Mouse Line
All FKBP and FRB vectors were obtained from ARIAD Pharmaceut-
icals (Cambridge, MA; http://www.ariad.com/regulationkits/index.
html). VAMP/Syb MIST was created by fusing rat VAMP2/synapto-
brevin with two domains of FKBP (36V) tagged with hemagglutinin
tag (HA). Synaptophysin-mEGFP-FRB2 was created by fusing two
domains of FRB to the C terminus of Synaptophysin-EGFP (from
Dr. Jane Sullivan) and by substituting the monomeric version of
EGFP (Zacharias et al., 2002) for the wild-type protein in the original
fusion. StxTM-based mislocalizer consisted of a transmembrane
domain of rat Syntaxin1 fused at the C terminus to myc-tagged
FKBP2. Adenoviral vector expressed VAMP-FKBP(36V)2-HA-IRES-
VenusYFP under the control of pCAG promoter. Woodchuck hepa-
titis virus posttranscriptional regulatory element, WPRE, (Zufferey
et al., 1999) (from Dr. T.J. Hope) was included in the transgene to
enhance expression levels. Adenovirus was produced by ViraQuest
Incorporated (North Liberty, IA). Viral titer wasw1010 pfu/ml. Lenti-
viral vector expressed VAMP/Syb MIST and EGFP from a bidirec-
tional ubiquitin-based promoter (Amendola et al., 2005).
To target VAMP/Syb MIST to Purkinje neurons, VAMP-FKBP
(36V)2-HA-IRES2-EGFP-WPRE was subcloned into pL7-DATG/1B
vector from Dr. J. Oberdick) (Zhang et al., 2001). The transgene
was separated from the vector by restriction digestion at flanking
sites, gel-purified, dialyzed, and microinjected into the pronuclei of
fertilized eggs. To assess the expression pattern of the transgene,
150 mM thick coronal vibratome sections were stained with anti-
EGFP antibody (Molecular Probes, Portland, OR) and imaged using
a 203 NA 0.95 objective (Olympus) on a custom-built two-photon
microscope. The transgenic mice used in this study were maintained
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Institutes of Health and the Cold Spring Harbor Laboratory Institu-
tional Animal Care and Use Committee.
Dissociated Neuronal Culture
For the FM dye screen, dissociated hippocampal cultures were pre-
pared from embryonic rat pups (E17–E19) as described (Evans et al.,
1998). For FM dye destaining kinetics measurements and for elec-
trophysiological recordings, dissociated hippocampal cocultures
were prepared from postnatal rat pups (P2–P3) as described (Deak
et al., 2004).
FM Dye Measurements
Dissociated cultures were transfected using effectene (Qiagen, Va-
lencia, CA) for the FM dye screen or they were infected with lentivirus
for the measurement of destaining kinetics at 6 days in vitro (6 DIV)
and used for experiments at 14 DIV.
The FM dye screen consisted of a series of fluid exchanges in
6-well plates containing transfected dissociated neurons: preincu-
bation in Neurobasal medium (Invitrogen, Carlsbad, CA) supple-
mented with 100 mM Cd2+, vehicle, or dimerizer; stimulation with
hyperkalemic solution (30 mM KCl, 2mM Ca2+, and 2mM Mg2+ in
Tyrode’s solution) for 2 min; a 2 min rest period; 2 min staining in
30 mM KCl with 10 mM FM 4-64; 15 min wash with Neurobasal me-
dium containing CellTracker Blue (Molecular Probes, Eugene, OR)
to stain living neurons, and then incubation at 37ºC for 20 min. Cov-
erslips were then fixed with 4% paraformaldehyde. All solutions
contained 10 mM NBQX and 50 mM DL-APV to prevent network activ-
ity. All solutions in the positive control condition contained 0.01%
(vol/vol) ethanol for homodimerization systems or 0.001% (vol/vol)
DMSO for heterodimerization systems. All solutions in the negative
control condition contained 100 mM Cd2+ to block synaptic transmis-
sion. All solutions in the dimerizer condition contained 10 nM
AP20187 for homodimerization experiments or 100 nM AP21967
for heterodimerization experiments. For reversal experiments, this
procedure was performed omitting the FM dye and then was re-
peated after 12 hr in the presence of FM dye and omitting the vehicle
or dimerizer. Coverslips were imaged immediately after fixation on
an Olympus microscope (Olympus, Melville, NY) using a 603 objec-
tive (NA 1.3; Olympus), a Xenon lamp, a CCD (Orca ER II; Hama-
matsu, Hamamatsu City, Japan), and commercial software (Slide-
book; Intelligent Imaging Innovations, Inc., Denver, CO).
Each FM dye screen experiment consisted of three to six cover-
slips of hippocampal dissociated neurons in the vehicle and drug
conditions and two coverslips in the Cd2+ condition. Coverslips
were analyzed by a researcher blind to whether dimerizer or vehicle
had been added in the experiment. Up to ten fields of view, measur-
ing 8991 mm by 6605 mm each, were selected randomly from each
coverslip. In the vehicle and drug conditions, at least 150 axon seg-
ments were selected for analysis from these fields of view, again
with the researcher blind to the condition. All axon segments were
selected from each field of view, unless they obviously overlapped
with nonspecific fluorescent background. The peaks on these
axon segments were then detected, yielding 1000–1500 peaks both
for the vehicle and drug conditions for each experiment. These
peaks were then averaged in each condition and used to calculate
the blocking index.
To quantify the inactivation of FM dye staining in the dimerizer
condition, we used custom software programmed in Matlab (Math-
works, Natick, MA) to detect and measure the FM 4-64 staining on
transfected axons. The mean of the FM dye peaks in each condition
were used to estimate the extent of block:
Block index =
CFMvehicleD2 CFMdrugD
CFMvehicleD2 CFMCd2 + D
(1)
The size of the readily releasable pool and FM dye destaining
kinetics were measured using field stimulation and time-lapse imag-
ing (Murthy et al., 1997; Ryan and Smith, 1995). Dissociated hippo-
campal cocultures infected with lentivirus carrying either EGFP or
VAMP/Syb-MIST were exposed to 10 mM FM 4-64, stimulated at
30 Hz for 1 min using field stimulation (1 ms duration at 20 V/cm
across platinum electrodes; S48 Stimulator; Grass Medical Instru-
ments, Quincy, MA;), exposed to FM 4-64 for an additional 30 s,and than washed for 15 min in Tyrode’s solution. All solutions con-
tained 10 mM NBQX and 10 mM CPP to block recurrent activity. Fields
of view were then randomly selected and destained at 30 Hz stimu-
lation, while images were acquired at 0.2 Hz. Quantitative measure-
ments of the destaining kinetics were obtained by manually select-
ing ROIs of 3 3 3 pixels in area (approximately 0.7 mm 3 0.7 mm).
The pixel intensity in each ROI was averaged, and a fluorescence
change for each ROI was calculated by subtracting the baseline in-
tensity from the mean intensity of the final three images. The rate of
perfusion was approximately 1 ml/min, and all experiments were
performed at room temperature.
In Utero Transgene Delivery
In utero surgery was performed as described (Saito and Nakatsuji,
2001). In brief, E15.5–E16.5 timed-pregnant mice were kept anesthe-
tized with continuous flow of isoflurane/oxygen, and adenovirus
expressing VAMP/Syb MIST or plasmid expressing myc-FKBP2-
StxTM-IRES-Sph-mGFP-FRB2 was injected, using glass micropip-
ettes, into the lateral ventricle of embryos through the uterine wall.
For plasmid electroporation, the square electric pulse was applied
to the embryos by holding them with forceps-type electrodes along
the anterior-posterior axis.
Electrophysiology
Cortical brain slices (300 mm thick) were cut from young (P9–P14)
mice using a vibrating blade microtome (VT1000S; Leica Microsys-
tems). Chilled cutting solution consisted of 110 mM choline chloride,
25 mM NaHCO3, 25 mM D-glucose, 11.6 mM sodium ascorbate,
7 mM MgSO4, 3.1 mM sodium pyruvate, 2.5 mM KCl, 1.25 mM
NaH2PO4, and 0.5 mM CaCl2. Slices were then transferred to artificial
cerebrospinal fluid (ACSF) consisting of 127 mM NaCl, 25 mM
NaHCO3, 25 mM D-glucose, 2.5 mM KCl, 2 mM MgCl2,1 mM
CaCl2, and 1.25 mM NaH2PO4, aerated with 95% O2/5% CO2. Slices
in ACSF were first incubated at 34ºC for 0.5 hr and then maintained at
room temperature prior to use. For recordings, ACSF contained
4 mM MgCl2, 4 mM CaCl2, and 5mM CPP.
Neurons were visualized with infrared differential interference
contrast optics, and patched using borosilicate electrodes (resis-
tances, 4–7 MU). Access resistances were in the range 10–30 MU.
Intracellular solution consisted of 120 mM CsMeSO3, 20 mM CsCl,
4 mM NaCl, 10 mM HEPES, 10 mM BAPTA, 4 mM Mg2ATP, and
0.3 mM Na2GTP, 14 mM sodium phosphocreatine, 3 mM ascorbate,
and 0.1 Alexa-594 (Molecular Probes); pH was adjusted to 7.25 with
CsOH. Excitatory currents were measured at a holding potential
of265 mV, close to reversal for fast inhibition. MIST-expressing neu-
rons were stimulated with a tungsten bipolar electrode in the middle
of the transfected region, and monosynaptic responses were re-
corded from cells within 200 mM of the electrode. Responses were
amplified (Multiclamp; Axon Instruments), filtered at 1 kHz, and dig-
itized at 10 kHz. Custom software written in Matlab (MathWorks, Na-
tick, MA) was used for electrophysiological acquisition and data
analysis.
Homodimerizer (AP20187) and heterodimerizer (AP21967) re-
agents (ARIAD Pharmaceuticals, Cambridge, MA) were dissolved
in DMSO to 100 mM and 500 mM, respectively. Following acquisition
of baseline evoked responses, the appropriate dimerizer was added
to the perfusion at a 1:1000 dilution for final concentrations of
100 nM and 500 nM. The monomeric antagonist AP21998 was added
to 5 mM.
For IPSC recordings in dissociated neuronal cultures at 14–16 DIV,
synaptic responses were triggered through a local extracellular
electrode (FHC Inc.) and recorded in the whole-cell mode using
a Multiclamp 700A amplifier (Axon Instruments, Inc.) in the presence
of blockers of excitatory transmission, NBQX (50 mM) and CPP
(5 mM). The whole-cell pipette solution contained 110 mM KCl,
30 mM K gluconate, 10 mM HEPES, 10 mM EGTA, 2 mM Na-GTP,
2 mM MgCl2, and 1 mM QX-314 (pH, 7.3). The bath solution
contained ACSF supplemented with 2 mM CaCl2 and 1 mM MgCl2.
Following acquisition of baseline evoked responses, the homodi-
merizer (AP20187) was added to the bath at a final concentration
of 200 nM.
Spontaneous activity in dissociated cultures was recorded in the
current-clamp mode. The whole-cell pipette solution contained:
120 mM K gluconate, 5 mM NaCl, 2 mM MgCl2, 0.1 mM CaCl2,
Neuron
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15 mM sodium phosphocreatine, (pH, 7.25; 290 mOsm). Cultures
were perfused with ACSF supplemented with 30 mM bicuculline, 2
mM CaCl2, and 1 mM MgCl2. Sister cultures were treated at physio-
logical temperature with: (1) vehicle for 3 hr, (2) 50 nM of the homo-
dimerizer for 3 hr, (3) 50 nM of the homodimerizer for 1 hr followed by
medium for 1 hr, or (4) 50 nM of the homodimerizer for 1 hr followed
by medium for 2 hr. In all cases, 30 mM bicuculline was also added to
the medium throughout the duration of the treatment. For each con-
dition, 20–30 traces 5 s long were acquired per cell, for 5–7 cells per
condition. The amount of both subthreshold and suprathreshold
spontaneous activity was quantified by calculating the average
standard deviation of the traces for each cell. Within each experi-
ment, the data were normalized to the average spontaneous activity
in vehicle-treated cultures. Three to six independent experiments
were done for each condition.
Animal Behavior
Rotarod testing was performed as described (Rustay et al., 2003).
Briefly, the AccuRotor Rota Rod (AccuScan Instruments, Inc.,
Columbus, OH) with 6.3 cm diameter dowels was used for the ex-
periments. Dowel surfaces were covered with 320 grit sandpaper
to provide a uniform surface. For the experiment during learning,
transgenic animals or wild-type littermates were placed on the rod
rotating at a constant speed of 30 rpm. Performance was scored
from the very first session. One session of 10 runs was performed
daily with the five best runs being scored for each animal. After
the first session, animals were injected, with use of a Hamilton sy-
ringe, into the lateral ventricle 1 mm lateral and 0.2 mm caudal of
Bregma with 0.5 nmol of AP20187 in a total volume of 0.25 ml. For
the experiment following saturation of learning, animals were chal-
lenged to a ramp protocol, with the rod accelerating to 80 rpm
over a period of 1 min. Animals were extensively prehandled to re-
duce the stress, and they were acquainted with the task. Surgery
was then performed to implant a cannula (Plastics One, Roanoke,
VA) into the skull for injections into the lateral ventricle. The animals
were allowed to recover from surgery and readjust to the task. One
session of 10 runs was performed daily, with the five best runs being
scored for each animal. Animals were considered to have reached
saturation when the performance of all animals was not varying by
more than 20% from session to session for 3 days. At that time,
baseline performance was scored, and animals were injected intra-
ventricularly with 0.5 nmol of AP20187 in a total volume of 1 ml over
a period of 3 min using a peristaltic pump. Injections were performed
at the end of the baseline run and about 16 hr before the next ses-
sion, to reduce the effect of handling on rotarod performance.
In both experiments, latency to fall was scored, and the results
were normalized for each animal to the mean score of the session
on the day prior to dimerizer injection. All data were acquired with
the investigator blind to the genotype of the animals. Significance
of the difference between predimerizer and postdimerizer scores,
as well as that between transgenic and wild-type littermates, was
analyzed using two-way ANOVA.
Error bars denote the standard error of the mean (6SEM).
Supplemental Data
Supplemental Data include one figure and can be found with this
article online at http://www.neuron.org/cgi/content/full/48/5/727/
DC1/.
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